Macdonald, F R <br/><br/>
The novel sodium glucose transporter 2 inhibitor dapagliflozin sustains pancreatic function and preserves islet morphology in obese, diabetic rats.  [electronic resource] 

 -  Diabetes, obesity & metabolism  Nov 2010 
 - 1004-12 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1463-1326 
<br/><br/><label>Standard No.: </label>10.1111/j.1463-1326.2010.01291.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Benzhydryl Compounds<br/>Diabetes Mellitus, Type 2--complications<br/>Female<br/>Glucosides--pharmacology<br/>Hyperglycemia--drug therapy<br/>Islets of Langerhans--cytology<br/>Obesity--drug therapy<br/>Pancreas--drug effects<br/>Rats<br/>Rats, Zucker<br/>Sodium-Glucose Transporter 2 Inhibitors